Head of Hit Discovery at AstraZeneca. The group is responsible for generating high quality starting points for AstraZeneca. In addition, the group works extensively with academic centres of excellence through open innovation and strategic collaborations to support academic drug discovery.
Keynote: “Learnings from AstraZeneca’s Open Innovation Program” (presentation available here)
Dr. Garry Pairaudeau spoke of his success with opening up his non-core research results to facilitate further collaborative research: “Don´t try to manage Innovation, that will be a disaster, try rather to focus what idea you really want to test for further development”
The presentation covers:
- Innovation process and OI experience at AstraZeneca
- Target Innovation and open ecosystem
- Biggest barriers to success in innovation
